FILTER

FILTERED ARTICLE RESULTS

Infectious Diseases: Addressing Growing Resistance

April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.

Finding Funding: The Diversification of the Biotech Financing Landscape

March 27, 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.

The Winning Formula: Building the Number One Biopharmaceutical Supercluster

February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.

Quality: A Means for Value Creation

June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.

Regulating Quality

June 19, 2017
Maintaining Safeguards Whilst Lowering Barriers to Market Entry.

Innovation: The Industry’s Backbone

May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.

Logistics and Distribution: From Factory to Patient

May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.

Paying the Price: U.S. Biopharma Industry

March 17, 2017
Slashing drug prices might benefit patients in the short term, but at what cost?

Pooling Its Force: U.S. Biopharmaceutical Industry Channels R&D Focus Amid Changing Tides

March 01, 2017
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Ontario Mining and Toronto's Global Reach 2025 - Digital Interactive

2024 was marked a ‘super year’ for elections by the UN, with 72 countries and almost half the world’s population heading to the polls, impacting the global mining sector with each vote cast. This election uncertainty was accompanied by familiar issues for Ontario’s miners, with labor shortages, challenging equity markets, and cost inflation dominating the discourse of industry professionals across the value chain.

PARTNER EVENTS